Trending
After tinkering with the biology of the broadly appealing anti-inflammatory NLRP3 pathway, NodThera is now plotting its pivotal trial plans for 2027.
Vertex Pharmaceuticals is making the largest acquisition in its history, beefing up its commercial portfolio with a $10 billion takeover of Crinetics Pharmace...
Its becoming Hengrui Pharmas world, and some Western drugmakers are just living in it. Chinas largest pharma company, which boasts one of the biggest pipelines
A fibrosis biotech has reeled in $76 million to get clinical data on three experimental medicines over the next two years. Mediar Therapeutics raised the
Have a news tip or want to get in touch with our editorial team? We're here to help.
Plot C3-C Jaypee Wishtown Sector 129 Noida Uttar Pradesh 201304 India